Peter Fuller

Peter Fuller has extensive experience in the pharmaceutical industry, currently serving as a Senior Director at Merck since August 2012, where responsibilities have included roles as Director, Associate Principal Scientist, and Sr. Scientist. Prior to this, Peter Fuller worked as an NIH Postdoctoral Fellow at Harvard University from May 2009 to July 2012, focusing on a research project related to Aflastatin A under the guidance of Professor David A. Peter Fuller holds a Ph.D. in Chemistry from the University at Buffalo, obtained in 2009, and a B.S. in Biology from Clarkson University, completed in 2003.